Supernus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $25.53-$40.28 |
Market Cap | $2.1B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $651.9M |
Revenue Growth (YoY) | 14.2% |
Gross Profit (12 Mos) | $580.5M |
Diluted EPS | $1.07 |
News
See moreYahoo Finance • yesterday
BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
Yahoo Finance • yesterday
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
Yahoo Finance • 2 days ago
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 652 |
